Gary Woodnutt - ContraFect Corp VP Devel
Insider
Gary Woodnutt is VP Devel of ContraFect Corp
| Age | 67 |
| Phone | 914 207 2300 |
| Web | https://www.contrafect.com |
ContraFect Corp Management Efficiency
The company has return on total asset (ROA) of (1.1744) % which means that it has lost $1.1744 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.0875) %, meaning that it created substantial loss on money invested by shareholders. ContraFect Corp's management efficiency ratios could be used to measure how well ContraFect Corp manages its routine affairs as well as how well it operates its assets and liabilities.ContraFect Corp currently holds 2.88 M in liabilities with Debt to Equity (D/E) ratio of 0.24, which may suggest the company is not taking enough advantage from borrowing. ContraFect Corp has a current ratio of 1.79, which is within standard range for the sector. Note, when we think about ContraFect Corp's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Chester III | Revelation Biosciences | 45 | |
| Diane Esq | Windtree Therapeutics | 55 | |
| John CPA | Unicycive Therapeutics | 63 | |
| David Hale | Dermata Therapeutics | 76 | |
| Sharon McBrayer | Palisade Bio | N/A | |
| James Foster | Virax Biolabs Group | 40 | |
| Donald Picker | Cns Pharmaceuticals | 79 | |
| Annie Rasmussen | Allarity Therapeutics | 67 | |
| CPA CTP | Cns Pharmaceuticals | 44 | |
| Gerald Proehl | Dermata Therapeutics | 66 | |
| Waldemar Priebe | Cns Pharmaceuticals | N/A | |
| Ronald Dundore | Windtree Therapeutics | 69 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| Jason Davis | Virax Biolabs Group | 53 | |
| Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
| James Rolke | Revelation Biosciences | 56 | |
| Tracy Rarick | Windtree Therapeutics | N/A | |
| MD DrSc | Allarity Therapeutics | 81 | |
| Joan Brown | Allarity Therapeutics | 70 | |
| Steen Knudsen | Allarity Therapeutics | 64 | |
| James JD | Allarity Therapeutics | 55 | |
Management Performance
| Return On Equity | -6.09 | |||
| Return On Asset | -1.17 |
ContraFect Corp Leadership Team
Elected by the shareholders, the ContraFect Corp's board of directors comprises two types of representatives: ContraFect Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ContraFect. The board's role is to monitor ContraFect Corp's management team and ensure that shareholders' interests are well served. ContraFect Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ContraFect Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| SPHR PHR, VP HR | ||
| Natalie JD, Corp Counsel | ||
| Gary Woodnutt, VP Devel | ||
| FACP FACP, CEO Chairman |
ContraFect Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ContraFect Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.09 | |||
| Return On Asset | -1.17 | |||
| Current Valuation | (2.32 M) | |||
| Shares Outstanding | 10.7 M | |||
| Shares Owned By Insiders | 0.65 % | |||
| Shares Owned By Institutions | 6.13 % | |||
| Number Of Shares Shorted | 115.97 K | |||
| Price To Earning | 21.36 X | |||
| Price To Book | 0.44 X | |||
| Gross Profit | (1.61 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |